Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;33(4):429-434.
doi: 10.3803/EnM.2018.33.4.429.

Primary Aldosteronism and Cerebrovascular Diseases

Zheng Wei Chen  1   2 , Chi Sheng Hung  1 , Vin Cent Wu  1 , Yen Hung Lin  3 ; TAIPAI study group
Affiliations
Review

Primary Aldosteronism and Cerebrovascular Diseases

Zheng Wei Chen et al. Endocrinol Metab (Seoul). 2018 Dec.

Abstract

As diagnostic techniques have advanced, primary aldosteronism (PA) has emerged as the most common cause of secondary hypertension. The excess of aldosterone caused by PA resulted in not only cardiovascular complications, including coronary artery disease, myocardial infarction, arrhythmia, and heart failure, but also cerebrovascular complications, such as stroke and transient ischemic attack. Moreover, PA is associated more closely with these conditions than is essential hypertension. In this review, we present up-to-date findings on the association between PA and cerebrovascular diseases.

Keywords: Cerebrovascular disorders; Primary aldosteronism; Stroke.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

    1. Gyamlani G, Headley CM, Naseer A, Valaulikar GS, Geraci SA. Primary aldosteronism: diagnosis and management. Am J Med Sci. 2016;352:391–398. - PubMed
    1. Rossi GP. Prevalence and diagnosis of primary aldosteronism. Curr Hypertens Rep. 2010;12:342–348. - PubMed
    1. Vilela LAP, Almeida MQ. Diagnosis and management of primary aldosteronism. Arch Endocrinol Metab. 2017;61:305–312. - PMC - PubMed
    1. Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter Study in Japan. Hypertension. 2018;71:530–537. - PubMed
    1. Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120:439–448. - PubMed